Chris Newmarker
Publishes 1 feed
Drug Delivery Business
10 posts · contributor
Lately
Senseonics sees activist investor take a major stake
Abbott, Google to deliver glucose insights through artificial intelligence
Embecta Q3 results beat analyst expectations
ICU Medical Q2 results beat analyst expectations, driven by infusion systems
Senseonics more than doubles Q2 revenue in post-Ascensia era
6 diabetes tech companies you need to know
Tandem Diabetes Care seeing early benefits of new pay-as-you-go model
The 10 largest diabetes tech companies in the world in 2026
Diabetes Technology Innovations Special Report — 2026
Insulet slightly lowers 2026 sales growth outlook despite Q2 beats
Everything on this page was read from markup Chris Newmarker published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON